Andreas Klimpel

1.4k total citations
24 papers, 991 citations indexed

About

Andreas Klimpel is a scholar working on Surgery, Pharmacology and Hematology. According to data from OpenAlex, Andreas Klimpel has authored 24 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Pharmacology and 5 papers in Hematology. Recurrent topics in Andreas Klimpel's work include Drug-Induced Hepatotoxicity and Protection (6 papers), Poisoning and overdose treatments (4 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). Andreas Klimpel is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (6 papers), Poisoning and overdose treatments (4 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (4 papers). Andreas Klimpel collaborates with scholars based in Germany, United States and Switzerland. Andreas Klimpel's co-authors include Elisabeth Bronder, Edeltraut Garbe, Frank Andersohn, Walter Schill, Johannes Haerting, Beate Pesch, Ulrich Ranft, Giselle Sarganas, Michael Thomae and Reinhold Kreutz and has published in prestigious journals such as International Journal of Molecular Sciences, International Journal of Epidemiology and British Journal of Haematology.

In The Last Decade

Andreas Klimpel

24 papers receiving 947 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Klimpel Germany 18 169 162 159 134 129 24 991
Joseph K. McLaughlin United States 10 298 1.8× 47 0.3× 84 0.5× 49 0.4× 291 2.3× 10 1.1k
Albert W. Dreisbach United States 20 205 1.2× 179 1.1× 25 0.2× 72 0.5× 259 2.0× 34 1.6k
Daniela Di Giuseppe Sweden 23 103 0.6× 45 0.3× 31 0.2× 120 0.9× 174 1.3× 71 1.8k
Donald A. Feinfeld United States 22 200 1.2× 144 0.9× 26 0.2× 54 0.4× 248 1.9× 63 1.2k
Wolfgang Pommer Germany 14 188 1.1× 104 0.6× 32 0.2× 40 0.3× 292 2.3× 71 1.0k
Sandra Milić Croatia 23 670 4.0× 81 0.5× 30 0.2× 100 0.7× 109 0.8× 70 2.5k
Flore Duranton France 13 176 1.0× 30 0.2× 57 0.4× 54 0.4× 113 0.9× 33 1.5k
Emilio González Parra Spain 13 93 0.6× 115 0.7× 48 0.3× 27 0.2× 89 0.7× 40 831
Bancha Satirapoj Thailand 24 228 1.3× 29 0.2× 45 0.3× 71 0.5× 118 0.9× 104 1.6k
Alessandra Bettiol Italy 26 135 0.8× 42 0.3× 46 0.3× 45 0.3× 466 3.6× 106 1.9k

Countries citing papers authored by Andreas Klimpel

Since Specialization
Citations

This map shows the geographic impact of Andreas Klimpel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Klimpel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Klimpel more than expected).

Fields of papers citing papers by Andreas Klimpel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Klimpel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Klimpel. The network helps show where Andreas Klimpel may publish in the future.

Co-authorship network of co-authors of Andreas Klimpel

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Klimpel. A scholar is included among the top collaborators of Andreas Klimpel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Klimpel. Andreas Klimpel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Douros, Antonios, Elisabeth Bronder, Andreas Klimpel, et al.. (2017). Drug-induced kidney injury: A large case series from the Berlin Case-Control Surveillance Study. Clinical Nephrology. 89(1). 18–26. 12 indexed citations
2.
Douros, Antonios, et al.. (2016). Tocilizumab-induced pancreatitis: case report and review of data from the FDA Adverse Event Reporting System. Journal of Clinical Pharmacy and Therapeutics. 41(6). 718–721. 22 indexed citations
3.
Huber, Matthias, Frank Andersohn, Giselle Sarganas, et al.. (2014). Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case–Control Surveillance Study. European Journal of Clinical Pharmacology. 71(2). 219–227. 70 indexed citations
4.
Sarganas, Giselle, Edeltraut Garbe, Andreas Klimpel, et al.. (2013). Epidemiology of symptomatic drug-induced long QT syndrome and torsade de pointes in Germany. EP Europace. 16(1). 101–108. 105 indexed citations
5.
Huber, Matthias, Frank Andersohn, Elisabeth Bronder, et al.. (2013). Drug-induced agranulocytosis in the Berlin case–control surveillance study. European Journal of Clinical Pharmacology. 70(3). 339–345. 34 indexed citations
6.
Douros, Antonios, Elisabeth Bronder, Frank Andersohn, et al.. (2013). Drug-induced acute pancreatitis: results from the hospital-based Berlin case-control surveillance study of 102 cases. Alimentary Pharmacology & Therapeutics. 38(7). 825–834. 23 indexed citations
7.
Douros, Antonios, Elisabeth Bronder, Frank Andersohn, et al.. (2013). Flupirtine-induced liver injury—Seven cases from the Berlin Case–control Surveillance Study and review of the German spontaneous adverse drug reaction reporting database. European Journal of Clinical Pharmacology. 70(4). 453–459. 18 indexed citations
8.
Douros, Antonios, Wolfgang Kauffmann, Elisabeth Bronder, et al.. (2013). Ramipril-Induced Liver Injury: Case Report and Review of the Literature. American Journal of Hypertension. 26(9). 1070–1075. 20 indexed citations
9.
Sarganas, Giselle, Hans‐Dieter Orzechowski, Andreas Klimpel, et al.. (2012). Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system. Neuro-Oncology. 14(5). 541–546. 22 indexed citations
10.
Garbe, Edeltraut, Frank Andersohn, Elisabeth Bronder, et al.. (2011). Drug induced immune haemolytic anaemia in the Berlin Case‐Control Surveillance Study. British Journal of Haematology. 154(5). 644–653. 78 indexed citations
11.
Garbe, Edeltraut, Frank Andersohn, Elisabeth Bronder, et al.. (2011). Drug-induced immune thrombocytopaenia: results from the Berlin Case–Control Surveillance Study. European Journal of Clinical Pharmacology. 68(5). 821–832. 50 indexed citations
12.
13.
Andersohn, Frank, et al.. (2009). Citalopram-Induced Bleeding Due to Severe Thrombocytopenia. Psychosomatics. 50(3). 297–298. 17 indexed citations
14.
Andersohn, Frank, Elisabeth Bronder, Andreas Klimpel, & Edeltraut Garbe. (2004). Proportion of drug‐related serious rare blood dyscrasias: Estimates from the Berlin Case‐Control Surveillance Study. American Journal of Hematology. 77(3). 316–318. 31 indexed citations
15.
Pesch, Beate, et al.. (2000). Occupational risk factors for renal cell carcinoma: agent-specific results from a case-control study in Germany. International Journal of Epidemiology. 29(6). 1014–1024. 211 indexed citations
16.
Pesch, Beate, et al.. (2000). Occupational risk factors for urothelial carcinoma: agent-specific results from a case-control study in Germany. International Journal of Epidemiology. 29(2). 238–247. 45 indexed citations
17.
Pommer, Wolfgang, Elisabeth Bronder, Andreas Klimpel, et al.. (1999). Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study. Nephrology Dialysis Transplantation. 14(12). 2892–2897. 58 indexed citations
18.
Bronder, Elisabeth, Andreas Klimpel, Uwe Helmert, et al.. (1999). Analgetika und laxantien als risikofaktoren f�r krebs der ableitenden Harnwege?Ergebnisse der Berliner Urothelkarzinom-Studie (BUS). Sozial- und Präventivmedizin. 44(3). 117–125. 2 indexed citations
19.
Bronder, Elisabeth, Andreas Klimpel, Wolfgang Pommer, & M. Molzahn. (1990). Daten zum chronischen Schmerzmittelgebrauch. Sozial- und Präventivmedizin. 35(4-5). 147–151. 3 indexed citations
20.
Pommer, Wolfgang, Elisabeth Bronder, Eberhard Greiser, et al.. (1989). Regular Analgesic Intake and the Risk of End-Stage Renal Failure. American Journal of Nephrology. 9(5). 403–412. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph K. McLaughlin Breakdown of academic impact, for papers by Albert W. Dreisbach Breakdown of academic impact, for papers by Daniela Di Giuseppe Breakdown of academic impact, for papers by Donald A. Feinfeld Breakdown of academic impact, for papers by Wolfgang Pommer Breakdown of academic impact, for papers by Sandra Milić Breakdown of academic impact, for papers by Flore Duranton Breakdown of academic impact, for papers by Emilio González Parra Breakdown of academic impact, for papers by Bancha Satirapoj Breakdown of academic impact, for papers by Alessandra Bettiol
Rankless by CCL
2026